On June 2, 2022 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported the Company’s participation in the following upcoming investor and industry conferences to be held in June 2022 (Press release, Genprex, JUN 2, 2022, View Source [SID1234615486]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: LD Micro Invitational
Virtual Presentation Date: Available on-demand within the virtual platform for all delegates beginning June 8 at 4:00 p.m. PT
Presenter: Ryan Confer, Genprex’s Chief Financial Officer
A recording of this presentation will be available for replay on Genprex’s website for a period of time.
Event: BIO International Convention